KEVEYIS: payments to doctors
Payments that named KEVEYIS as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $331K
- Providers
- 6,890
- Transactions
- 11,754
- Average per transaction
- $28
The per-transaction average — $28 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 6,890 providers the average total is $48, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Xeris Pharmaceuticals, Inc. | $240,086 | 72.5% |
| Strongbridge US Inc. | $91,012 | 27.5% |